Laurvick, C. L. et al. Rett syndrome in Australia: a review of the epidemiology. J. Pediatr. 148, 347–352 (2006).

Article  PubMed  Google Scholar 

Rett, A. On a unusual brain atrophy syndrome in hyperammonemia in childhood [German]. Wien. Med. Wochenschr. 116, 723–726 (1966).

PubMed  CAS  Google Scholar 

Hagberg, B., Aicardi, J., Dias, K. & Ramos, O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann. Neurol. 14, 471–479 (1983).

Article  PubMed  CAS  Google Scholar 

Neul, J. L. et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944–950 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Neul, J. L. et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70, 1313–1321 (2008).

Article  PubMed  CAS  Google Scholar 

Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185–188 (1999).

Article  PubMed  CAS  Google Scholar 

Percy, A. K. et al. When Rett syndrome is due to genes other than MECP2. Transl. Sci. Rare Dis. 3, 49–53 (2018).

PubMed  PubMed Central  Google Scholar 

Sajan, S. A. et al. Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2. Genet. Med. 19, 13–19 (2017).

Article  PubMed  Google Scholar 

Suter, B., Treadwell-Deering, D., Zoghbi, H. Y., Glaze, D. G. & Neul, J. L. Brief report: MECP2 mutations in people without Rett syndrome. J. Autism Dev. Disord. 44, 703–711 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Tarquinio, D. C. et al. The changing face of survival in Rett syndrome and MECP2-related disorders. Pediatr. Neurol. 53, 402–411 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Neul, J. L. et al. The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. Am. J. Med. Genet. B Neuropsychiatr. Genet. 180, 55–67 (2019).

Article  PubMed  CAS  Google Scholar 

Tillotson, R. & Bird, A. The molecular basis of MeCP2 function in the brain. J. Mol. Biol. 432, 1602–1623 (2020).

Article  PubMed  CAS  Google Scholar 

Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224–1229 (2008).

Article  PubMed  PubMed Central  CAS  Google Scholar 

D’Mello, S. R. 3rd MECP2 and the biology of MECP2 duplication syndrome. J. Neurochem. 159, 29–60 (2021).

Article  PubMed  Google Scholar 

Nan, X., Campoy, F. J. & Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471–481 (1997).

Article  PubMed  CAS  Google Scholar 

Skene, P. J. et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457–468 (2010).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S. & Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417–1430 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Ballas, N., Lioy, D. T., Grunseich, C. & Mandel, G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 12, 311–317 (2009).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Maezawa, I., Swanberg, S., Harvey, D., LaSalle, J. M. & Jin, L. W. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci. 29, 5051–5061 (2009).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fu, C. et al. Multisystem comorbidities in classic Rett syndrome: a scoping review. BMJ Paediatr. Open. 4, e000731 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Fu, C. et al. Consensus guidelines on managing Rett syndrome across the lifespan. BMJ Paediatr. Open. 4, e000717 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Buchanan, C. B. et al. Behavioral profiles in Rett syndrome: data from the Natural History Study. Brain Dev. 41, 123–134 (2019).

Article  PubMed  Google Scholar 

Glaze, D. G. et al. Epilepsy and the natural history of Rett syndrome. Neurology 74, 909–912 (2010).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Harrison, D. J. & Webb, P. J. Scoliosis in the Rett syndrome: natural history and treatment. Brain Dev. 12, 154–156 (1990).

Article  PubMed  CAS  Google Scholar 

Neul, J. L. et al. Developmental delay in Rett syndrome: data from the Natural History Study. J. Neurodev. Disord. 6, 20 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Percy, A. K. et al. Rett syndrome diagnostic criteria: lessons from the Natural History Study. Ann. Neurol. 68, 951–955 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Stallworth, J. L. et al. Hand stereotypies: lessons from the Rett Syndrome Natural History Study. Neurology 92, e2594–e2603 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Neul, J. L. et al. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat. Med. 29, 1468–1475 (2023).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Petriti, U., Dudman, D. C., Scosyrev, E. & Lopez-Leon, S. Global prevalence of Rett syndrome: systematic review and meta-analysis. Syst. Rev. 12, 5 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Hagberg, B., Goutières, F., Hanefeld, F., Rett, A. & Wilson, J. Rett syndrome: criteria for inclusion and exclusion. Brain Dev. 7, 372–373 (1985).

Article  PubMed  CAS  Google Scholar 

Kozinetz, C. A. et al. Epidemiology of Rett syndrome: a population-based registry. Pediatrics 91, 445–450 (1993).

Article  PubMed  CAS  Google Scholar 

Fehr, S. et al. Trends in the diagnosis of Rett syndrome in Australia. Pediatr. Res. 70, 313–319 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Sarajlija, A. et al. Epidemiology of Rett syndrome in Serbia: prevalence, incidence and survival. Neuroepidemiology 44, 1–5 (2015).